GlaxoSmithKline PLC’s consumer business gets another shot in the arm following sales growth in its latest quarter and a recent OTC switch launch as alli returns nearly a year after the weight loss drug’s recall from U.S. stores.
Alli Return In U.S. Fattens Glaxo’s Consumer Outlook
GSK Consumer Healthcare says alli would be available starting Feb. 25 in most stores in the U.S. and Puerto Rico in “improved tamper-evident packaging.” Despite the product’s checkered history, its return marks another boost for Glaxo’s consumer outlook.